Literature DB >> 32694777

Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity.

Fernando F Anhê1,2, Benjamin Anderschou Holbech Jensen1,3, Thibault V Varin1, Florence Servant4, Sebastian Van Blerk4, Denis Richard1, Simon Marceau1, Michael Surette2, Laurent Biertho1, Benjamin Lelouvier4, Jonathan D Schertzer2, André Tchernof1, André Marette5.   

Abstract

Visceral obesity is a key risk factor for type 2 diabetes (T2D). Whereas gut dysbiosis appears to be instrumental for this relationship, whether gut-associated signatures translocate to extra-intestinal tissues and how this affects host metabolism remain elusive. Here we provide a comparative analysis of the microbial profile found in plasma, liver and in three distinct adipose tissues of individuals with morbid obesity. We explored how these tissue microbial signatures vary between individuals with normoglycaemia and those with T2D that were matched for body mass index. We identified tissue-specific signatures with higher bacterial load in the liver and omental adipose tissue. Gut commensals, but also environmental bacteria, showed tissue- and T2D-specific compartmentalisation. T2D signatures were most evident in mesenteric adipose tissue, in which individuals with diabetes displayed reduced bacterial diversity concomitant with fewer Gram-positive bacteria, such as Faecalibacterium, as opposed to enhanced levels of typically opportunistic Gram-negative Enterobacteriaceae. Plasma samples of individuals with diabetes were similarly enriched in Enterobacteriaceae, including the pathobiont Escherichia-Shigella. Our work provides evidence for the presence of selective plasma and tissue microbial signatures in individuals with severe obesity and identifies new potential microbial targets and biomarkers of T2D.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32694777     DOI: 10.1038/s42255-020-0178-9

Source DB:  PubMed          Journal:  Nat Metab        ISSN: 2522-5812


  59 in total

Review 1.  Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity.

Authors:  Herbert Tilg; Timon E Adolph; Michael Dudek; Percy Knolle
Journal:  Nat Metab       Date:  2021-12-20

Review 2.  Gut microbiome, liver immunology, and liver diseases.

Authors:  Rui Wang; Ruqi Tang; Bo Li; Xiong Ma; Bernd Schnabl; Herbert Tilg
Journal:  Cell Mol Immunol       Date:  2020-12-14       Impact factor: 11.530

3.  Peripheral and central regulation of insulin by the intestine and microbiome.

Authors:  Jonathan D Schertzer; Tony K T Lam
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-14       Impact factor: 4.310

Review 4.  Emerging concepts in intestinal immune control of obesity-related metabolic disease.

Authors:  Saad Khan; Helen Luck; Shawn Winer; Daniel A Winer
Journal:  Nat Commun       Date:  2021-05-10       Impact factor: 14.919

5.  Insulin resistance corresponds with a progressive increase in NOD1 in high fat diet-fed mice.

Authors:  Aditya Sharma; Sushmita Singh; Alok Mishra; Amit K Rai; Ishbal Ahmad; Shadab Ahmad; Farah Gulzar; Jonathan D Schertzer; Ashutosh Shrivastava; Akhilesh K Tamrakar
Journal:  Endocrine       Date:  2022-02-02       Impact factor: 3.633

6.  CRIg+ Macrophages Prevent Gut Microbial DNA-Containing Extracellular Vesicle-Induced Tissue Inflammation and Insulin Resistance.

Authors:  Zhenlong Luo; Yudong Ji; Hong Gao; Felipe Castellani Gomes Dos Reis; Gautam Bandyopadhyay; Zhongmou Jin; Crystal Ly; Ya-Ju Chang; Dinghong Zhang; Deepak Kumar; Wei Ying
Journal:  Gastroenterology       Date:  2020-11-02       Impact factor: 22.682

7.  Bacterial DNAemia is associated with serum zonulin levels in older subjects.

Authors:  Giorgio Gargari; Giacomo Mantegazza; Valentina Taverniti; Cristian Del Bo'; Stefano Bernardi; Cristina Andres-Lacueva; Raul González-Domínguez; Paul A Kroon; Mark S Winterbone; Antonio Cherubini; Patrizia Riso; Simone Guglielmetti
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

8.  Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Authors:  Anne-Gaëlle Goubet; Agathe Dubuisson; Laurence Zitvogel; Lisa Derosa; Arthur Geraud; François-Xavier Danlos; Safae Terrisse; Carolina Alves Costa Silva; Damien Drubay; Lea Touri; Marion Picard; Marine Mazzenga; Aymeric Silvin; Garett Dunsmore; Yacine Haddad; Eugenie Pizzato; Pierre Ly; Caroline Flament; Cléa Melenotte; Eric Solary; Michaela Fontenay; Gabriel Garcia; Corinne Balleyguier; Nathalie Lassau; Markus Maeurer; Claudia Grajeda-Iglesias; Nitharsshini Nirmalathasan; Fanny Aprahamian; Sylvère Durand; Oliver Kepp; Gladys Ferrere; Cassandra Thelemaque; Imran Lahmar; Jean-Eudes Fahrner; Lydia Meziani; Abdelhakim Ahmed-Belkacem; Nadia Saïdani; Bernard La Scola; Didier Raoult; Stéphanie Gentile; Sébastien Cortaredona; Giuseppe Ippolito; Benjamin Lelouvier; Alain Roulet; Fabrice Andre; Fabrice Barlesi; Jean-Charles Soria; Caroline Pradon; Emmanuelle Gallois; Fanny Pommeret; Emeline Colomba; Florent Ginhoux; Suzanne Kazandjian; Arielle Elkrief; Bertrand Routy; Makoto Miyara; Guy Gorochov; Eric Deutsch; Laurence Albiges; Annabelle Stoclin; Bertrand Gachot; Anne Florin; Mansouria Merad; Florian Scotte; Souad Assaad; Guido Kroemer; Jean-Yves Blay; Aurélien Marabelle; Frank Griscelli
Journal:  Cell Death Differ       Date:  2021-07-06       Impact factor: 15.828

9.  Relationship Between Multidrug-Resistant Enterobacterales and Obesity in Older Adults.

Authors:  Navaneeth Narayanan; Tiffany Lin; David Vinarov; Thomas Bucek; Liya Johnson; Cheryl Mathew; Saira Chaudhry; Luigi Brunetti
Journal:  Infect Drug Resist       Date:  2021-06-30       Impact factor: 4.003

10.  Hepatic microbiome in healthy lean and obese humans.

Authors:  Malte Palm Suppli; Jonatan Ising Bagger; Benjamin Lelouvier; Amandine Broha; Mia Demant; Merete Juhl Kønig; Charlotte Strandberg; Asger Lund; Tina Vilsbøll; Filip Krag Knop
Journal:  JHEP Rep       Date:  2021-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.